These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 23447481

  • 21. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study.
    Bauer SR, Aloi JJ, Ahrens CL, Yeh JY, Culver DA, Reddy AJ.
    J Crit Care; 2010 Jun; 25(2):362.e7-362.e11. PubMed ID: 19926252
    [Abstract] [Full Text] [Related]

  • 22. Low-dose vasopressin in the treatment of septic shock in sheep.
    Sun Q, Dimopoulos G, Nguyen DN, Tu Z, Nagy N, Hoang AD, Rogiers P, De Backer D, Vincent JL.
    Am J Respir Crit Care Med; 2003 Aug 15; 168(4):481-6. PubMed ID: 12791578
    [Abstract] [Full Text] [Related]

  • 23. Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients.
    Russell JA, Vincent JL, Kjølbye AL, Olsson H, Blemings A, Spapen H, Carl P, Laterre PF, Grundemar L.
    Crit Care; 2017 Aug 15; 21(1):213. PubMed ID: 28807037
    [Abstract] [Full Text] [Related]

  • 24. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
    Bauer SR, Sacha GL, Reddy AJ.
    Ann Pharmacother; 2020 Apr 15; 54(4):314-321. PubMed ID: 31679395
    [Abstract] [Full Text] [Related]

  • 25. Comparative Effectiveness of Second Vasoactive Agents in Septic Shock Refractory to Norepinephrine.
    Nguyen HB, Lu S, Possagnoli I, Stokes P.
    J Intensive Care Med; 2017 Aug 15; 32(7):451-459. PubMed ID: 27189952
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.
    Erwin BL, Denaburg MA, Barker AB, McArdle PJ, Windham ST, Morgan CJ.
    Crit Care Med; 2017 Dec 15; 45(12):e1226-e1232. PubMed ID: 28991825
    [Abstract] [Full Text] [Related]

  • 27. Septic shock--vasopressin, norepinephrine, and urgency.
    Parrillo JE.
    N Engl J Med; 2008 Feb 28; 358(9):954-6. PubMed ID: 18305271
    [No Abstract] [Full Text] [Related]

  • 28. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR, Glaxo Wellcome International Septic Shock Study Group.
    Crit Care Med; 2004 Jan 28; 32(1):13-20. PubMed ID: 14707555
    [Abstract] [Full Text] [Related]

  • 29. Therapeutic goal achievements during severe sepsis and septic shock resuscitation and their association with patients' outcomes.
    Permpikul C, Sringam P, Tongyoo S.
    J Med Assoc Thai; 2014 Mar 28; 97 Suppl 3():S176-83. PubMed ID: 24772596
    [Abstract] [Full Text] [Related]

  • 30. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
    Colon Hidalgo D, Patel J, Masic D, Park D, Rech MA.
    J Crit Care; 2020 Feb 28; 55():145-148. PubMed ID: 31731173
    [Abstract] [Full Text] [Related]

  • 31. Push-Dose Vasopressin for Hypotension in Septic Shock.
    Nowadly CD, Catlin JR, Fontenette RW.
    J Emerg Med; 2020 Feb 28; 58(2):313-316. PubMed ID: 32173168
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Low plasma vasopressin/norepinephrine ratio predicts septic shock.
    Lin IY, Ma HP, Lin AC, Chong CF, Lin CM, Wang TL.
    Am J Emerg Med; 2005 Oct 28; 23(6):718-24. PubMed ID: 16182977
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cost-effectiveness of second-line vasopressors for the treatment of septic shock.
    Lam SW, Barreto EF, Scott R, Kashani KB, Khanna AK, Bauer SR.
    J Crit Care; 2020 Feb 28; 55():48-55. PubMed ID: 31706118
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: a matched cohort study of the effect on survival.
    Sawa N, Ubara Y, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hoshino J, Suwabe T, Uchida N, Wake A, Taniguchi S, Takaichi K.
    Clin Nephrol; 2013 Jun 28; 79(6):463-70. PubMed ID: 23253903
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.